Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nifty Pharma (NIPHARM)
Comprehensive information about the CNX Pharma index. More information is available in the different sections of the CNX Pharma page, such as: historical data, charts, technical analysis and others.
NSE
Currency in INR
25,781.65
-36.15(-0.14%)
Closed·
Day's Range
25,636.60
25,931.45
52 wk Range
21,149.90
27,255.05
Day's Range
25,636.6025,931.45
52 wk Range
21,149.9027,255.05
- Prev. Close
- 25,817.8
- Open
- 25,855.6
- 1-Year Change
- 16.6422%
- Volume
- 16,536,421
- Average Volume (3m)
- 23,324,442
- Prev. Close
- 25,817.8
- Open
- 25,855.6
- 1-Year Change
- 16.6422%
- Volume
- 16,536,421
- Average Volume (3m)
- 23,324,442
- Day's Range
- 25,636.6-25,931.45
- 52 wk Range
- 21,149.9-27,255.05
- Prev. Close
- 25,817.8
- Open
- 25,855.6
- 1-Year Change
- 16.6422%
- Volume
- 16,536,421
- Average Volume (3m)
- 23,324,442
- Day's Range
- 25,636.6-25,931.45
- 52 wk Range
- 21,149.9-27,255.05
How do you feel today about NIPHARM?
Vote to see community's results!
or
Mankind Pharma receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Cadila Healthcare receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mankind Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
| Name | Last | Prev. | High | Low | Chg. % | Vol. | Time | Price | |
|---|---|---|---|---|---|---|---|---|---|
BION Biocon Ltd. | 349.20 | 352.00 | 353.00 | 348.00 | -0,80% | 1.88M | 349.20-0,80% | 16/10 | |
LAUL Laurus Labs Ltd | 2,060.10 | 2,018.50 | 2,086.00 | 2,028.70 | +2,06% | 1.61M | 2,060.10+2,06% | 16/10 | |
ZYDU Zydus Lifesciences Ltd | 1,123.00 | 1,140.20 | 1,146.50 | 1,123.00 | -1,51% | 1.6M | 1,123.00-1,51% | 16/10 | |
SUN Sun Pharmaceutical Industries Ltd. | 1,758.80 | 1,764.00 | 1,764.90 | 1,743.50 | -0,29% | 1.52M | 1,758.80-0,29% | 16/10 | |
REDY Dr Reddy’s Laboratories Ltd | 1,233.00 | 1,218.80 | 1,233.00 | 1,214.10 | +1,17% | 1.26M | 1,233.00+1,17% | 16/10 |
Top Gainers
| Name | Price |
|---|---|
LAUL Laurus Labs | 2,060.10+41.60+2,06% |
GRAN Granules India | 825.35+13.40+1,65% |
DIVI Divi's | 9,144.50+114.50+1,27% |
REDY Dr Reddy’s Laboratories | 1,233.00+14.20+1,17% |
ABOT Abbott India | 26,170.00+100.00+0,38% |
Top Losers
| Name | Price |
|---|---|
IPCA Ipca Laboratories | 1,832.60-80.50-4,21% |
MNKI Mankind Pharma | 2,275.50-72.10-3,07% |
ZYDU Zydus Lifesciences | 1,123.00-17.20-1,51% |
ALKE Alkem Laboratories Ltd | 5,050.00-70.50-1,38% |
GLEN Glenmark Pharmaceuticals | 2,226.70-23.80-1,06% |
Beat the S&P 500
Picked from S&P 500, refined by AI. This strategy studies all 500 stocks, then selects the elite 20 most likely to outperform the market in the next month.
S&P 500 Outperformance+794,5%
Annualised Return+20,7%
Stocks in this strategy
AAA:AAAA
aaa aaaaaaa aaaa aaaaaaaaaaa
AAA:AAAA
aaa aaaaaaa aaaa aaaaaaaaaaa
AAA:AAAA
aaa aaaaaaa aaaa aaaaaaaaaaa
AAA:AAAA
aaa aaaaaaa aaaa aaaaaaaaaaa
FAQ
How Is the Nifty Pharma Doing Today?
The Nifty Pharma live stock price is 25 781,65.
What is the Nifty Pharma Ticker Symbol?
NIPHARM is the ticker symbol of the Nifty Pharma index.
What was the opening value for Nifty Pharma today?
Today, the Nifty Pharma opened at 25 855,60.
What is the trading volume for Nifty Pharma?
The current volume for Nifty Pharma is 16 536 421.
What is the day's trading range for Nifty Pharma?
The Nifty Pharma stock price has ranged from 25 636,60 to 25 931,45.
What is the 52-week range for Nifty Pharma?
The Nifty Pharma stock price has ranged from 21 149,90 to 27 255,05 over the past 52 weeks.
From a Technical Analysis Perspective, Is Nifty Pharma a Buy or Sell?
Based on technical indicators and moving averages, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.